APOTEKEREN A.M.B.A.: Financial statements 2024
CVR: 16938106
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
APOTEKEREN A.M.B.A. (CVR 16938106) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 74,631,133 and a net result of DKK 65,238,502 compared with DKK 69,485,166 the year before. That is a decrease of 4.9% compared with the year before. Equity in the 2024 report amounted to DKK 43,259,340. The solvency ratio was 95.1%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 74,631,133
- Profit/Loss
- DKK 65,238,502
- Equity
- DKK 43,259,340
- Total Assets
- DKK 45,490,765
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 74.6M | 65.2M | 43.3M | 12 |
| 2023 | - | 78.4M | 69.5M | 49.5M | 12 |
| 2022 | - | 70.1M | 61.1M | 42.3M | 12 |
| 2021 | - | 71.7M | 63.1M | 45.7M | 11 |
| 2020 | - | 66.2M | 57.5M | 38.6M | 11 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
APOTEKEREN A.M.B.A. has published its annual report for 2023. Gross profit came to DKK 78,436,007, and the net result was DKK 69,485,166.
As of April 26, 2024, Peter Oksbjerg Bak has joined the board of directors of APOTEKEREN A.M.B.A..
As of April 26, 2024, Jette Kristensen has left the board of directors of APOTEKEREN A.M.B.A..
About APOTEKEREN A.M.B.A.
APOTEKEREN A.M.B.A. is a Danish company of the type Andelsselskab (-forening) med begrænset ansvar based in København Ø, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dorte Brix Nagell. The board consists of Trine Frost Hansen (chair), Jakob Møller, Christina Weidemann Pedersen and Kristian Østergaard Nielsen. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 75,345,843 and a net result of DKK 65,040,255 compared with DKK 65,238,502 the year before. Equity in the 2025 report amounted to DKK 42,276,964.
